SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-22-025060
Filing Date
2022-10-28
Accepted
2022-10-28 16:05:29
Documents
14
Period of Report
2022-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A arav20221027_8ka.htm   iXBRL 8-K/A 33656
2 EXHIBIT 10.1 ex_438684.htm EX-10.1 265343
  Complete submission text file 0001437749-22-025060.txt   487278

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arav-20221024.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20221024_def.xml EX-101.DEF 10822
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20221024_lab.xml EX-101.LAB 14444
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20221024_pre.xml EX-101.PRE 10868
8 EXTRACTED XBRL INSTANCE DOCUMENT arav20221027_8ka_htm.xml XML 2448
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36361 | Film No.: 221341867
SIC: 2834 Pharmaceutical Preparations